- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Expression patterns of immune checkpoints in acute myeloid leukemia ; volume:13 ; number:1 ; day:3 ; month:4 ; year:2020 ; pages:1-5 ; date:12.2020
Journal of hematology & oncology ; 13, Heft 1 (3.4.2020), 1-5, 12.2020
- Urheber
-
Chen, Cunte
Liang, Chaofeng
Wang, Shunqing
Chio, Chi Leong
Zhang, Yuping
Zeng, Chengwu
Chen, Shaohua
Wang, Caixia
Li, Yangqiu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-020-00853-x
- URN
-
urn:nbn:de:101:1-2020062115283986176542
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Cunte
- Liang, Chaofeng
- Wang, Shunqing
- Chio, Chi Leong
- Zhang, Yuping
- Zeng, Chengwu
- Chen, Shaohua
- Wang, Caixia
- Li, Yangqiu
- SpringerLink (Online service)
Ähnliche Objekte (12)
The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways
SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints
Can Immune Therapy Cure Acute Myeloid Leukemia?
Targeting immune checkpoints in hematological malignancies
Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
Immune receptor repertoires in pediatric and adult acute myeloid leukemia
Varied functions of immune checkpoints during cancer metastasis
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
Calreticulin mediates immune recognition of acute myeloid leukemia cells in vivo
Immune evasion in acute myeloid leukemia: current concepts and future directions
Improvement of immune thrombocytopenia with imatinib therapy following chronic myeloid leukemia
Untersuchung der Rolle des Immun-Checkpoints VISTA im Pankreaskarzinom
The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways
SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints
Can Immune Therapy Cure Acute Myeloid Leukemia?
Targeting immune checkpoints in hematological malignancies
Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
Immune receptor repertoires in pediatric and adult acute myeloid leukemia
Varied functions of immune checkpoints during cancer metastasis
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
Calreticulin mediates immune recognition of acute myeloid leukemia cells in vivo
Immune evasion in acute myeloid leukemia: current concepts and future directions
Improvement of immune thrombocytopenia with imatinib therapy following chronic myeloid leukemia
Untersuchung der Rolle des Immun-Checkpoints VISTA im Pankreaskarzinom
The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways
SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints
Can Immune Therapy Cure Acute Myeloid Leukemia?
Targeting immune checkpoints in hematological malignancies
Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
Immune receptor repertoires in pediatric and adult acute myeloid leukemia
Varied functions of immune checkpoints during cancer metastasis
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
Calreticulin mediates immune recognition of acute myeloid leukemia cells in vivo
Immune evasion in acute myeloid leukemia: current concepts and future directions
Improvement of immune thrombocytopenia with imatinib therapy following chronic myeloid leukemia